SB
SBRA.US Sabra Healthcare REIT Inc
- Market cap
- USD 5.30B
- P/E
- 75.0x
- P/B
- 1.61x
- ROE
- 2.1%
- Dividend yield
- 5.46%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SBRA.US undervalued?
Graham numberSBRA.US trades 132.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sabra Healthcare REIT Inc fundamental analysis
No fundamental analysis for Sabra Healthcare REIT Inc yet.
Sabra Healthcare REIT Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sabra Healthcare REIT Inc
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Full company profileSabra Healthcare REIT Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sabra Healthcare REIT Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 261M | 406M | 623M | 668M | 599M | 570M | 625M | 648M | 703M | 775M | 943M |
| Gross Profit | 255M | 388M | 574M | 558M | 467M | 428M | 462M | 452M | 476M | 504M | 568M |
| Operating Income | 161M | 224M | 307M | 528M | 241M | 211M | 235M | 222M | 257M | 264M | 95.1M |
| EBITDA | 205M | 361M | 621M | 528M | 416M | 166M | 217M | 312M | 413M | 457M | 407M |
| Net Income | 70.3M | 158M | 279M | 69.0M | 138M | -113M | -77.6M | 13.8M | 127M | 156M | 59.0M |
| EPS | 1.07 | 1.50 | 1.56 | 0.37 | 0.67 | -0.52 | -0.34 | 0.06 | 0.54 | 0.64 | 0.23 |
| Balance Sheet | |||||||||||
| Total Assets | 2.27B | 7.03B | 6.67B | 6.07B | 5.99B | 5.97B | 5.75B | 5.39B | 5.30B | 5.49B | 5.43B |
| Total Liabilities | 1.25B | 3.60B | 3.41B | 2.58B | 2.58B | 2.59B | 2.69B | 2.58B | 2.56B | 2.67B | 2.59B |
| Shareholders' Equity | 1.02B | 3.43B | 3.25B | 3.49B | 3.41B | 3.38B | 3.06B | 2.80B | 2.74B | 2.82B | 2.84B |
| Cash & Short-term Investments | 25.7M | 519M | 50.2M | 39.1M | 59.1M | 112M | 49.3M | 41.3M | 60.5M | 71.5M | 36.2M |
| Total Debt | 1.21B | 3.39B | 3.23B | 2.48B | 3.68B | 4.18B | 2.55B | 2.45B | 2.44B | 2.55B | 2.44B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 177M | 133M | 359M | 372M | 355M | 356M | 316M | 301M | 311M | 349M | 418M |
| Capital Expenditure | 56.6M | 334M | 93.4M | 252M | 106M | 33.6M | 147M | 5.24M | 0.00 | 0.00 | 54.7M |
| Free Cash Flow | 120M | -201M | 265M | 120M | 249M | 323M | 169M | 295M | 311M | 349M | 363M |
| Ratios | |||||||||||
| ROE | 6.9% | 4.6% | 8.6% | 2.0% | 4.1% | -3.4% | -2.5% | 0.5% | 4.6% | 5.5% | 2.1% |
| ROA | 3.1% | 2.3% | 4.2% | 1.1% | 2.3% | -1.9% | -1.4% | 0.3% | 2.4% | 2.8% | 1.1% |
| Net Profit Margin | 27.0% | 39.0% | 44.8% | 10.3% | 23.1% | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% | 6.3% |
| Debt to Equity | 1.19x | 0.99x | 0.99x | 0.71x | 1.08x | 1.24x | 0.83x | 0.87x | 0.89x | 0.90x | 0.86x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Sabra Healthcare REIT Inc dividends
- Dividend yield
- 5.46%
- Forward dividend
- 1.20 USD
- Payout ratio
- 186.0%
- Ex-dividend date
- Nov 13, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 289M | 1.18 | 186.0% |
| 2024 | USD 280M | 1.19 | 221.1% |
| 2023 | USD 277M | 1.19 | 2,016.9% |
| 2022 | USD 277M | 1.20 | - |
| 2021 | USD 263M | 1.20 | - |
| 2020 | USD 278M | 1.34 | 201.1% |
| 2019 | USD 335M | 1.78 | 486.2% |
| 2018 | USD 325M | 1.82 | 116.5% |
| 2017 | USD 182M | 1.72 | 115.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:3 on Nov 16, 2010.
Who owns Sabra Healthcare REIT Inc
- Insiders 1.37%
- Institutions 98.63%
- Public & others 0.00%
- Shares outstanding 262M
- Free float 258M
Top funds holding SBRA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard Real Estate Index Investor | 9.55M | 3.65% | +0.72% | Sep 2026 |
| iShares Core S&P Mid-Cap ETF | 9.18M | 3.51% | +0.05% | Oct 2026 |
| Principal Real Estate Securities R5 | 8.14M | 3.11% | -1.47% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 8.05M | 3.07% | +0.32% | Sep 2026 |
| iShares Russell 2000 ETF | 6.48M | 2.47% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 5.75M | 2.19% | -1.04% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 3.74M | 1.43% | +1.55% | Sep 2026 |
| Fidelity Small Cap Index | 2.81M | 1.07% | +0.14% | Aug 2026 |
| iShares Russell 2000 Value ETF | 2.41M | 0.92% | 0.00% | Oct 2026 |
| Schwab US REIT ETF™ | 2.02M | 0.77% | 0.00% | Oct 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 1.89M | 0.72% | +2.42% | Sep 2026 |
| Vanguard Real Estate II Index | 1.69M | 0.65% | +0.72% | Sep 2026 |
| DFA Real Estate Securities I | 1.65M | 0.63% | +23.75% | Sep 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 1.54M | 0.59% | -0.26% | Oct 2026 |
| Nomura Small Cap Value A | 1.53M | 0.58% | 0.00% | Sep 2026 |
| Vanguard Russell 2000 ETF | 1.49M | 0.57% | +1.14% | Sep 2026 |
| State Street SPDR Port S&P 400 Md CpETF | 1.39M | 0.53% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 1.36M | 0.52% | +0.24% | Oct 2026 |
| Principal Global Real Estate Sec Instl | 1.28M | 0.49% | -1.95% | Sep 2026 |
| Fidelity Extended Market Index | 1.19M | 0.46% | -3.57% | Sep 2026 |
Top institutions holding SBRA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 41.6M | 15.89% | +6.44% | Jun 2026 |
| Principal Financial Group Inc | 23.8M | 9.10% | -3.52% | Sep 2026 |
| Vanguard Portfolio Management, LLC | 23.4M | 8.91% | +0.90% | Jun 2026 |
| State Street Corp | 12.3M | 4.70% | +1.70% | Jun 2026 |
| Vanguard Capital Management, LLC | 11.3M | 4.33% | +1.05% | Jun 2026 |
| Geode Capital Management, LLC | 7.91M | 3.02% | +6.15% | Jun 2026 |
| CenterSquare Investment Management LLC | 5.81M | 2.22% | +49.94% | Jun 2026 |
| Bank of America Corp | 5.30M | 2.02% | -2.00% | Jun 2026 |
| Charles Schwab Investment Management Inc | 4.84M | 1.85% | +1.41% | Jun 2026 |
| Nuveen, LLC | 4.46M | 1.70% | -33.09% | Jun 2026 |
| LaSalle Investment Management Securities LLC | 4.28M | 1.63% | +11.88% | Jun 2026 |
| Rush Island Management, LP | 4.21M | 1.61% | +163.44% | Jun 2026 |
| Northern Trust Corp | 3.86M | 1.47% | +0.84% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 3.80M | 1.45% | +3.77% | Sep 2026 |
| The Goldman Sachs Group Inc | 3.44M | 1.31% | -7.88% | Jun 2026 |
| Sumitomo Mitsui Trust Group Inc | 3.44M | 1.31% | +7.19% | Jun 2026 |
| Duff & Phelps Inv Mgmt Co (IL) | 3.33M | 1.27% | +17.79% | Jun 2026 |
| NORGES BANK | 3.31M | 1.27% | +8.32% | Jun 2026 |
| Bank of New York Mellon Corp | 3.24M | 1.24% | -1.87% | Jun 2026 |
| JPMorgan Chase & Co | 3.23M | 1.23% | -60.59% | Jun 2026 |
Sabra Healthcare REIT Inc company profile
- Company name
- Sabra Healthcare REIT Inc
- Ticker
- SBRA.US
- Exchange
- USA Stocks
- Listed since
- Apr 2, 2002
- Sector
- Real Estate
- Industry
- Diversified REITs
- Employees
- 58
- Fiscal year end
- December
- Address
- 1781 Flight Way, Tustin, CA, United States, 92782-0539
- Phone
- 888 393 8248
- Website
- sabrahealth.com
About Sabra Healthcare REIT Inc
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Sabra Healthcare REIT Inc management
6- Mr. Richard K. MatrosChairman, President & CEO · born 1954
- Mr. Michael Lourenco Costa CPAExecutive VP, CFO & Treasurer · born 1979
- Mr. Darrin L. SmithChief Investment Officer, Secretary & Executive VP · born 1969
- Ms. Jessica FloresExecutive VP & Chief Accounting Officer · born 1983
- Mr. Peter W. NylandExecutive Vice President of Strategic Initiatives
- Mr. Lukas Michael Hartwich C.F.A.Executive Vice President of Finance